This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Novalix Deutschland Gmbh. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Thomas Neumann: Innovator in Antibody Purification Technologies
Introduction
Thomas Neumann is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of antibody purification. His innovative work has led to the development of advanced methods that enhance the efficiency of protein purification processes.
Latest Patents
One of Thomas Neumann's key patents is titled "Ligands for antibody and Fc-fusion protein purification by affinity chromatography IV." This invention relates to the use of a ligand-substituted matrix for the affinity purification of antibodies or their fragments. The matrix comprises a support material and at least one ligand covalently bonded to it. The ligand is represented by a specific formula, which is defined in the patent documentation. This innovation is crucial for improving the purification processes in biopharmaceutical production.
Career Highlights
Throughout his career, Thomas Neumann has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Novalix Deutschland GmbH and Graffinity Pharmaceuticals GmbH. His experience in these organizations has allowed him to refine his expertise in protein purification and related technologies.
Collaborations
Thomas Neumann has collaborated with various professionals in his field. Some of his notable coworkers include Marc Arnold and Inge Ott. These collaborations have contributed to the advancement of his research and the successful implementation of his inventions.
Conclusion
Thomas Neumann's contributions to antibody purification technologies exemplify the impact of innovative thinking in biotechnology. His patent and career achievements highlight the importance of advancements in this field.